The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients
about
Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval ProjectPsychological effects of treatment with new oral anticoagulants in elderly patients with atrial fibrillation: a preliminary reportAnticoagulated patient's perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy - study protocol for The Switching Study: a prospective coPatient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study.Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design.Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).[Atrial fibrillation and physical activity. An overview].Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolismPatient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study.Development and validation of a new questionnaire measuring treatment satisfaction in patients with non-valvular atrial fibrillation: SAFUCA®.Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial.Satisfaction with oral anticoagulants in patients with atrial fibrillation.Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy.COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
P2860
Q28647204-31B2B5F1-3D7B-4D84-8F2C-AE193C1C517AQ35065354-81537B61-DAB1-4048-AD3C-DDC8B92798AEQ36112493-4798E9BE-829B-4567-B9AF-74EA8D76D498Q36217719-BD6FA915-109B-440D-8E2B-592720EAD8B4Q39477719-23BABFE3-EFDA-4394-A922-EEC1BE231FF8Q40323287-741FB816-55E6-495A-B0DD-4A9A6D7A7C8DQ41313283-88C8E670-246A-484C-888C-8E3E8D0D0EA4Q42283151-2A6FBAD5-009C-44B7-BA78-290A4C4F4D89Q47126676-33A3C398-16A3-4465-9950-D7195D77CDEFQ47602971-FD4FF3AC-38EE-41A2-AC72-B56CA3BB155AQ49587052-3B90425F-F8C4-45A6-807D-75FB04C4349DQ50357227-738E81DE-3AE4-44EC-B6CC-A38E2BAC9012Q51749349-27AB4557-EEE0-4889-86A2-9DE441F6D0B4Q56515861-5E43B1C6-EBE3-45DF-94E7-7F32AFF3CF3F
P2860
The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The Anti-Clot Treatment Scale ...... enous thromboembolism patients
@ast
The Anti-Clot Treatment Scale ...... enous thromboembolism patients
@en
type
label
The Anti-Clot Treatment Scale ...... enous thromboembolism patients
@ast
The Anti-Clot Treatment Scale ...... enous thromboembolism patients
@en
prefLabel
The Anti-Clot Treatment Scale ...... enous thromboembolism patients
@ast
The Anti-Clot Treatment Scale ...... enous thromboembolism patients
@en
P2093
P2860
P356
P1476
The Anti-Clot Treatment Scale ...... enous thromboembolism patients
@en
P2093
Donna L Lamping
Luke Bamber
Sarah Smith
Stefan J Cano
P2860
P2888
P356
10.1186/1477-7525-10-120
P577
2012-09-26T00:00:00Z
P5875
P6179
1052009198